SPONSOR
Arsenal Biosciences, Inc.
Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Metastatic Castration Resistant Prostate Cancer (mCRPC)
Arsenal Biosciences, Inc. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Metastatic Castration Resistant Prostate Cancer (mCRPC).
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Arsenal Biosciences, Inc.
How many clinical trials has Arsenal Biosciences, Inc. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Arsenal Biosciences, Inc., of which 1 are actively recruiting participants. These trials cover conditions including Metastatic Castration Resistant Prostate Cancer (mCRPC). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Arsenal Biosciences, Inc. research focus on?
Arsenal Biosciences, Inc. clinical trials span Metastatic Castration Resistant Prostate Cancer (mCRPC). The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Arsenal Biosciences, Inc. clinical trial?
To participate in a Arsenal Biosciences, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Arsenal Biosciences, Inc. trials with current recruitment status updated daily.
Clinical Trials by Arsenal Biosciences, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology